Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study

被引:9
|
作者
Overcast, Wynton B. [1 ]
Zhang, Jianying [2 ]
Zynger, Debra L. [3 ]
Tozbikian, Gary H. [3 ]
机构
[1] Ohio State Univ, Coll Med, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, 320 Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Wexner Med Ctr, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
关键词
ASCO/CAP guidelines; Breast cancer; Equivocal category; HER2 immunohistochemistry (IHC); HER2 fluorescence in situ hybridization (FISH); IN-SITU HYBRIDIZATION; POLYMERASE CHAIN-REACTION; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; COPY NUMBER; CANCER; RECEPTOR; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; FISH;
D O I
10.1007/s00428-016-1951-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:203 / 212
页数:10
相关论文
共 50 条
  • [1] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Wynton B. Overcast
    Jianying Zhang
    Debra L. Zynger
    Gary H. Tozbikian
    Virchows Archiv, 2016, 469 : 203 - 212
  • [2] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Liu, Zhi-Hua
    Wang, Kun
    Lin, Dan-Yi
    Xu, Jie
    Chen, Jie
    Long, Xiao-Yu
    Ge, Yan
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Liu, Yan-Hui
    Xu, Fang-Ping
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 51 - 57
  • [3] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [4] The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases
    Zhang, Xiaofei
    Bleiweiss, Ira
    Jaffer, Shabnam
    Nayak, Anupma
    CLINICAL BREAST CANCER, 2017, 17 (06) : 486 - 492
  • [5] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Fan, Yao-Shan
    Casas, Carmen E.
    Peng, Jinghong
    Watkins, Melanie
    Fan, Lynn
    Chapman, Jennifer
    Ikpatt, Offiong Francis
    Gomez, Carmen
    Zhao, Wei
    Reis, Isildinha M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 457 - 462
  • [6] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Zhi-Hua Liu
    Kun Wang
    Dan-Yi Lin
    Jie Xu
    Jie Chen
    Xiao-Yu Long
    Yan Ge
    Xin-Lan Luo
    Ke-Ping Zhang
    Yan-Hui Liu
    Fang-Ping Xu
    Breast Cancer Research and Treatment, 2019, 175 : 51 - 57
  • [7] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    McLemore, Lauren E.
    Albarracin, Constance T.
    Gruschkus, Stephen K.
    Bassett, Roland L., Jr.
    Wu, Yun
    Dhamne, Sagar
    Yiml, Isaiah
    Lin, Kevin
    Bedrosian, Isabelle
    Sneigel, Nour
    Chen, Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 95 - 104
  • [8] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [9] Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations
    Hwang, Hye Won
    Hong, Soon Auck
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jong-Han
    Lee, Se Kyung
    Cho, Soo Youn
    Cho, Eun Yoon
    VIRCHOWS ARCHIV, 2022, 480 (04) : 749 - 758
  • [10] Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH
    Ragazzi, M.
    Bisagni, A.
    Gasparini, E.
    Kuhn, E.
    Bassano, C.
    Tamagnini, I.
    Foroni, M.
    Bortesi, M.
    Falco, G.
    Ferrari, G.
    Braglia, L.
    Savoldi, L.
    Bologna, A.
    Di Cicilia, R.
    Bisagni, G.
    Gardini, G.
    BREAST, 2017, 34 : 65 - 72